Research summary
Magnesium and Blood Sugar
Pooled human evidence links higher magnesium intake with lower type 2 diabetes risk and links magnesium supplementation with a small reduction in fasting plasma glucose, though larger trials are still needed.[1], [2]
Magnesium intake and type 2 diabetes risk
A meta-analysis of 13 prospective cohort studies, together involving 536,318 participants and 24,516 incident cases, reported that higher dietary magnesium intake was inversely associated with risk of type 2 diabetes. The pooled relative risk comparing higher with lower intake was 0.78 (95% CI 0.73-0.84). In a dose-response analysis, each additional 100 mg/day of magnesium intake corresponded to a relative risk of about 0.86, or roughly 14% lower risk per increment.[1]
Because these are observational cohort findings, they describe an association rather than a cause-and-effect relationship. The authors noted the inverse association was not substantially modified by geographic region, follow-up length, sex, or family history, and that little evidence of publication bias was seen.[1]
Magnesium supplementation and fasting plasma glucose
A separate systematic review and meta-analysis of randomized controlled trials examined magnesium supplementation in diabetic and nondiabetic adults. It reported a significant improvement in fasting plasma glucose, with a weighted mean difference of about -4.6 mg/dL versus control. The trials also showed favorable changes in HDL, LDL, triglycerides, and systolic blood pressure, and the glycemic effect appeared larger in diabetic subjects with low magnesium status.[2]
Strength and limits of the evidence
Both lines of evidence come from meta-analyses of human studies, which sit relatively high in the evidence hierarchy. Even so, the trial authors emphasized that larger randomized trials are still needed before robust clinical-practice guidance can be drawn, and the cohort data remain observational. The reported glycemic change from supplementation is modest in size.[2]
Limitations
The cohort meta-analysis can show association but not causation, and intake was based on dietary assessment rather than controlled dosing. The trial meta-analysis pooled studies using varied magnesium doses and durations, the average fasting-glucose change was small, and effects were strongest in people with low magnesium status. This page summarizes research findings and is not medical advice.[2]
References
- Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies.. Diabetes care. 2011. Systematic review and meta-analysis View source →
- Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2017. Systematic review and meta-analysis View source →